Silvercrest Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.34M	Buy	10,251 +430	+4%	+$140K	0.02%	476
2025 Q1	$2.65M	Buy	9,821 +4,930	+101%	+$1.33M	0.02%	502
2024 Q4	$1.15M	Buy	+4,891	New	+$1.15M	0.01%	598